19.01.2015 • NewsPeopleBiesterfeldBirger Kuck

Thomas Arnold to Become CEO of Biesterfeld

Thomas Arnold will become CEO of Biesterfeld with effect of April 1, 2015.
Thomas Arnold will become CEO of Biesterfeld with effect of April 1, 2015.

The Supervisory Board of Biesterfeld has appointed Thomas Arnold (54) as CEO with effect of April 1, 2015. Arnold, currently member of the board of Biesterfeld and Managing Director of Biesterfeld Spezialchemie, takes over from Birger Kuck, who will retire after eleven years as CEO and a total of 35 years with the company on March 31, 2015.

Arnold joined Biesterfeld in May 2013 and was appointed to the board of Biesterfeld in July 2014. Prior to this he held management positions in various renowned, international companies in the trade.

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read